ISDSF yields 20000.00% · JNJ yields 2.13%● Live data
📍 ISDSF pulled ahead of the other in Year 1
Combined, ISDSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ISDSF + JNJ for your $10,000?
iSIGN Media Solutions Inc., a data-focused software-as-a-service company, provides location-based security alert messaging and proximity marketing solutions in North America. The company provides Hybrid Analytics Location Observation, a software platform and listening device that offers a suite of functions specifically designed to maximize safety and security within a managed environment, such as school, hospital, shopping plaza, and concert venue; Hybrid Analytics Location Observation with facial recognition offers facial and object recognition modules; Passive Historical Aggregate Contact Tracing, an intelligent smart space analytics platform that utilizes publicly available anonymous interactions between mobile devices to accurately determine occupancy levels and movements of individuals. It offers InHome Care, a virtual intelligent in-home health care solution; and Smart Antenna solutions. In addition, it provides data management/broadcasting of commercial messaging and security alert messaging; purchases, sells, and leases hardware.; license agreements for the integration of hardware and technology into other companies' hardware; and data and analytic sales solutions. It serves advertisers, manufacturers, retailers, and advertising agencies. iSIGN Media Solutions Inc. was incorporated in 2007 and is headquartered in Richmond Hill, Canada.
Full ISDSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.